The hair transplant market in India has grown rapidly over the past decade, driven by rising concerns about appearance, lifestyle changes and increasing cases of hair loss among younger people. Affordable pricing compared to Western countries and advanced techniques such as Follicular Unit Extraction and Direct Hair Implantation have positioned India as a popular destination for both domestic and international patients. Metro cities like Delhi, Mumbai, Bengaluru and Hyderabad are hubs for reputed clinics. Celebrity influence, medical tourism and higher disposable incomes further fuel demand. This is the reason why its market is projected to expand steadily with increasing awareness and accessibility.
Keeping with the pace, Eugenix Hair Sciences has pioneered path-breaking innovations such as the Direct Hair Transplantation (DHT) technology, widely considered the gold standard in hair transplant methodology worldwide for over the past decade and a half, having conducted more than 18,000 successful hair transplant procedures for patients from over 90 countries.
Taking its mission to the next level, the organisation unveiled its Global Facility in Gurgaon to serve patients from India and across the world. The unveiling was graced by globally acclaimed singer Sonu Nigam, who praised it for its pioneering contributions and for spearheading India’s leadership in medical innovation.
Sonu Nigam said, ‘The truth is, many people do not know that the biggest breakthrough in modern hair transplants DHT was invented right here in India by Dr.Arika Bansal and Dr. Pradeep Sethi in 2013. What they created has now become the global gold standard, followed by doctors worldwide. I feel proud to see India leading the world in this field.
India has witnessed a rapid rise in demand for advanced hair care and restoration solutions over the past five years. The India hair care market generated revenue of about USD 5 billion in 2022 and is projected to reach USD 15.1 billion by 2030, growing at a CAGR of nearly 11%.
This growth is driven by rising awareness of scientifically backed solutions, demand for corrective procedures, and increasing medical tourism to India. These trends underline the significance of Eugenix’s innovations and the global relevance of the Gurgaon facility.
Dr. Sethi, Founder and Chairman of the organisation, said the new global facility reflects nearly two decades of innovation and a patient-first approach, blending advanced R&D with a spirit of service to create a world-class medical brand in India. Co-Founder and MD Dr. Arika Bansal added that Eugenix showcases the best of Indian medical expertise, combining scientific precision with artistry, and the new facility embodies this ethos on a global scale.
